NewcelX Ltd.

Public

SwitzerlandHealthcarehttps://newcelx.com/

NewcelX Ltd. is now publicly traded

The data on this page reflects NewcelX Ltd.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Seed Round

Aug 24, 2026

Total Funding Raised

$6.37M

Company Overview

NewcelX Ltd. is a biotechnology company that develops transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.

Sector

Healthcare

AI Layer

Non-AI

Keywords

regenerative medicinecell therapyhuman pluripotent stem cellhPSCbiopharmaceuticaldrug discoveryislet replacement therapyclinical-stage biotechsmall-molecule treatmentneurodegenerative diseasemetabolic diseaseoff-the-shelf therapybiotech startupclinical trialsALS treatment

NewcelX Ltd. Comparables

Compare NewcelX Ltd. with similar companies based on industry and business-model similarity.

NewcelX Ltd. comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

NewcelX Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed Round	Aug 24, 2026
Private Placement	May 13, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Rami Epstein

Chief Executive Officer, Member Of The Board Of Directors

Executive Team

Ronen Twito

Executive Chairman CEO, Executive Chairman CEO

Executive Team

Uri Ben-Or

Chief Financial Officer

Executive Team

NewcelX Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NewcelX Ltd. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSwitzerland

Employee Range28

Year Founded2025

Last FundingAug 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?